HEATHER QUIST: Open Payments
NPI 1861888729 · FENTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,070 in 56 payments from 21 companies in 2025. Trend: 2023 $1,166 · 2024 $1,246 · 2025 $1,070
Food & beverage: $1,070
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 16 | $153 |
| Lilly USA, LLC | 7 | $125 |
| Neurocrine BioSciences, Inc. | 1 | $118 |
| Novo Nordisk Inc | 5 | $102 |
| ABBVIE INC. | 3 | $84 |
| Axsome Therapeutics, Inc. | 3 | $63 |
| Lundbeck LLC | 2 | $57 |
| Amgen Inc. | 3 | $54 |
| Janssen Pharmaceuticals, Inc | 1 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
Products named: INGREZZA, PREVNAR 20, JARDIANCE, MOUNJARO, Auvelity, UBRELVY, Ozempic, OTEZLA.
Industry payments across MO — which companies pay providers there.
